185 related articles for article (PubMed ID: 6139671)
1. Cyproterone acetate in treatment of post-orchidectomy hot flushes. Double-blind cross-over trial.
Eaton AC; McGuire N
Lancet; 1983 Dec; 2(8363):1336-7. PubMed ID: 6139671
[TBL] [Abstract][Full Text] [Related]
2. Cyproterone and post-orchidectomy flushes.
Magill PJ; Stonier PD
Lancet; 1984 Jan; 1(8369):161. PubMed ID: 6140463
[No Abstract] [Full Text] [Related]
3. Cyproterone acetate for treatment of hot flashes after orchiectomy.
Moon TD
J Urol; 1985 Jul; 134(1):155-6. PubMed ID: 3159912
[No Abstract] [Full Text] [Related]
4. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Irani J; Salomon L; Oba R; Bouchard P; Mottet N
Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
[TBL] [Abstract][Full Text] [Related]
5. [Cyproterone acetate in the treatment of post-orchiectomy flushing].
Jansen JE; Hendriksen ON
Ugeskr Laeger; 1989 Feb; 151(9):560-1. PubMed ID: 2522257
[TBL] [Abstract][Full Text] [Related]
6. Cyproterone acetate in the management of prostatic cancer.
Tunn UW
Prog Clin Biol Res; 1989; 303():105-10. PubMed ID: 2528734
[No Abstract] [Full Text] [Related]
7. alpha-Methyldopa for climacteric hot flushes. A double-blind, randomized, cross-over study.
Andersen O; Engebretsen T; Solberg VM; Orbo A
Acta Obstet Gynecol Scand; 1986; 65(5):405-9. PubMed ID: 3535358
[TBL] [Abstract][Full Text] [Related]
8. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
Pavone-Macaluso M; Schröder FH; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R; Smith PH; Suciu S
Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735
[No Abstract] [Full Text] [Related]
9. Use of cyproterone acetate in prostate cancer.
Goldenberg SL; Bruchovsky N
Urol Clin North Am; 1991 Feb; 18(1):111-22. PubMed ID: 1825143
[TBL] [Abstract][Full Text] [Related]
10. The position of cyproterone acetate (CPA), a steroidal anti-androgen, in the treatment of prostate cancer.
de Voogt HJ
Prostate Suppl; 1992; 4():91-5. PubMed ID: 1533452
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of vasomotor syndrome in the treatment of advanced prostatic cancer: apropos of 37 cases].
Ronzoni G; De Giovanni L; Menchinelli P; Meneschincheri M
Arch Ital Urol Androl; 1998 Feb; 70(1):37-40. PubMed ID: 9549167
[TBL] [Abstract][Full Text] [Related]
12. Orchiectomy combined with cyproterone acetate or prednisone in the treatment of advanced prostatic carcinoma. A randomized clinical and endocrine study.
Sander S; Nissen-Meyer R; Aakvaag A
Scand J Urol Nephrol; 1982; 16(3):193-7. PubMed ID: 6219455
[TBL] [Abstract][Full Text] [Related]
13. Progestogens: therapeutic and adverse effects in early post-menopausal women.
Marslew U; Riis B; Christiansen C
Maturitas; 1991 Mar; 13(1):7-16. PubMed ID: 1830636
[TBL] [Abstract][Full Text] [Related]
14. Hot flushes: mechanism and prevention.
Radlmaier A; Bormacher K; Neumann F
Prog Clin Biol Res; 1990; 359():131-40; discussion 141-53. PubMed ID: 2149457
[No Abstract] [Full Text] [Related]
15. [Cyproterone acetate and cancer of the prostate. Experience in 46 cases].
Tauveron I; Hermabessière J
Therapie; 1988 May; 43(3):175-7. PubMed ID: 2971277
[No Abstract] [Full Text] [Related]
16. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
Robinson MR
Prog Clin Biol Res; 1987; 243A():383-90. PubMed ID: 2958863
[No Abstract] [Full Text] [Related]
17. Bleeding patterns during continuous combined estrogen-progestogen therapy.
Marslew U; Riis BJ; Christiansen C
Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1163-8. PubMed ID: 1827947
[TBL] [Abstract][Full Text] [Related]
18. Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment.
Greenwood R; Brummitt L; Burke B; Cunliffe WJ
Br Med J (Clin Res Ed); 1985 Nov; 291(6504):1231-5. PubMed ID: 2933119
[TBL] [Abstract][Full Text] [Related]
19. Short-term anti-androgen therapy and very long-acting depot gonadotrophin-releasing hormone agonist for prostatic cancer.
Waxman J
Prog Clin Biol Res; 1989; 303():61-8. PubMed ID: 2528741
[No Abstract] [Full Text] [Related]
20. EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
Robinson MR
Prog Clin Biol Res; 1988; 260():101-10. PubMed ID: 2966402
[No Abstract] [Full Text] [Related]
[Next] [New Search]